Sektor BioCryst Pharmaceuticals, Inc.

Aktien

896047

US09058V1035

BCRX

Biotechnologie

Markt geschlossen - 22:00:00 14.08.2026 % 5 Tage Veränd. 1. Jan.
9.740 USD -0.71% Intraday Chart für BioCryst Pharmaceuticals, Inc. +3.84% +24.87%
Hauptkonkurrenten
% % 5 Tage Veränd. 1 Monat Veränd. 3 Monate % 1. Jan. % 1 Jahr Veränd. 3 Jahre Veränd. 5 Jahre Veränd. 10 Jahre Kap.($)
-0.71%+3.84%0.00%+1.78%+24.87%+15.27%+36.41%-39.69%+93.25% 2.49 Mrd.
-1.90%+2.85%+24.88%+54.59%+75.68%+61.37%+102.88%+14.78% - 70.07 Mrd.
-3.21%-4.32%-4.07%+5.19%+1.87%+31.19%+59.75%+173.89%+5’245.53% 52.87 Mrd.
-2.05%-5.61%+12.38%+7.02%-28.90%-3.14%+454.89%+425.21%+938.96% 27.02 Mrd.
-1.27%-1.57%+18.17%+38.30%+43.58%+46.46%+6.09%-63.12% - 23.61 Mrd.
+1.05%-0.62%+2.98%+1.20%-2.22%-17.40%-13.36%-75.33% - 23.38 Mrd.
+3.81%+20.97%+25.00%+112.78%+254.02%+263.48%+552.47%+1’847.78%+900.81% 19.43 Mrd.
+0.10%+1.40%+8.98%+20.37%0.00%+38.98%-20.04%-31.29%+79.06% 18.75 Mrd.
-0.95%-3.52%+4.48%+19.71%+32.71%+20.04%+613.01% - - 15.85 Mrd.
+1.24%-5.23%-8.12%+0.27%+16.91%+33.19%+138.21%+180.31%+380.68% 12.7 Mrd.
+1.12%-1.25%+20.36%+8.61%+30.37%+360.86%+194.49%+43.01%+1’352.18% 12.24 Mrd.
+0.04%-0.49%-5.46%-5.99%-12.84%+36.67%+192.64%+498.11%+6’640.50% 11.73 Mrd.
-7.34%-4.00%+0.16%-22.46%-15.04%-41.53%+185.71%+116.70% - 11.27 Mrd.
-4.57%-4.30%-13.64%-26.35%-23.61%-49.49%+574.75%+68.69%+100.57% 10.65 Mrd.
+0.93%-3.43%-9.52%-5.73%+16.67%+91.45%+130.93%+130.58%+510.12% 10.31 Mrd.
+1.91%-1.06%+4.90%+37.21%+216.85%+515.66%+781.53%-31.14%-9.74% 9.14 Mrd.
-2.18%-6.43%-2.18%-10.28%+12.08%+4.20%+120.19%-25.28% - 9.01 Mrd.
+0.31%+0.74%+1.18%+121.09%+81.95%+185.28%+402.97%+280.50% - 8.98 Mrd.
-1.34%0.00%+3.31%+8.48%+25.86%+84.76%+26.24%+123.09% - 8.64 Mrd.
+0.87%+2.91%+1.90%+29.35%+15.60%+33.76%+426.45%+328.47% - 8.03 Mrd.
Durchschnitt -0.71%+1.42%+4.28%+19.76%+38.32%+85.55%+248.31%+208.70%+1’475.63% 18.31 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung -1.09%+0.56%+8.21%+25.13%+39.53%+69.35%+202.40%+203.94%+2’281.85%
  1. Börse
  2. Aktien
  3. 896047 Aktie
  4. Sektor BioCryst Pharmaceuticals, Inc.